Stop Calling It Analysis. Last Week It Was Touting
- Lindsay Timcke

- Jun 24
- 2 min read
Let me say the quiet part out loud. A lot of what passed for IPO analysis last week was not analysis, it was a sales pitch with a press pass.
SpaceX priced at 135, opened at 150, closed near 161 and blew past two trillion dollars in a day. Fine. Then came the parade of 400 and 1200 dollar targets on a company that lost nearly five billion dollars last year and trades at roughly ninety five times revenue, where Google went public near seven and Facebook near twenty. New Street says 165, Oppenheimer says 190, Morningstar ran the same filings and got 63, a fifty three percent discount. Same company, same documents, and a four hundred percent spread in opinion.
That gap is not insight, it is positioning, and somebody always knows which side of the trade they are on. I investigate fraud for a living, so I ask the one question the cheerleaders skip, what does the person talking get paid if you buy. SpaceX floated three percent of itself. A thin float plus forced index buying can print a price that has nothing to do with the business.
A director tied to Valor holds over seven percent and sits on both sides of roughly twenty billion in guaranteed GPU leases. That is not a footnote, that is a motive. Here is the part nobody wants to hear. Section 17b of the Securities Act has said for ninety years that if you are paid to talk up a stock you must disclose it, by source and by amount.
The SEC made Kim Kardashian pay over a million dollars for one undisclosed plug. It charged twenty seven outfits for running paid hype dressed up as independent research. It unsealed a hundred million dollar pump and dump built entirely on social media posts. The mechanics never change, manufacture a story, ride the retail stampede, sell into the noise, hand the loss to the little guy.
So when an anonymous account with no license, no track record, and no skin you can see, hands you a number with no math behind it, stop calling it a hot take. These people answer to no regulator, carry no liability, and vanish the moment the chart turns, while your money does not. A price target with no method and no disclosed interest is not research, it is an advertisement, and when the payment is hidden the statute already has a word for it. I am bullish on space, bullish on AI, bullish on the next decade, which is exactly why I refuse to let the carnival barkers price it.
Before you touch a single one of these names, demand the number, the method, and the motive. If even one is missing, ask the only question that matters, are they selling you the stock, or selling you?
